[HTML] nih.gov

[HTML][HTML] Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients

J Feng, Y Li, B Wei, L Guo, W Li, Q Xia… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background Rearranged during transfection (RET) rearrangement has been identified as
one of the crucial oncogenic drivers in non-small cell lung cancer (NSCLC). Recently, two …
被引用次数：17 相关文章 所有 8 个版本
[HTML] nih.gov

[HTML][HTML] Clinical characteristics and molecular patterns of RET-rearranged lung cancer in Chinese patients

K Zhang, H Chen, Y Wang, L Yang, C Zhou… - Oncology …, 2019 - ncbi.nlm.nih.gov
RET rearrangement has been proven as an oncogenic driver in patients with lung cancer.
However, the prevalence, clinical characteristics, molecular features, and therapeutic …
被引用次数：40 相关文章 所有 5 个版本

Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma

Z Song, X Yu, Y Zhang - Lung Cancer, 2016 - Elsevier
Background RET fusion gene is identified as a novel oncogene in a subset of non-small cell
lung cancer (NSCLC). However, few data are available about the prevalence …
被引用次数：42 相关文章 所有 7 个版本
[HTML] sciencedirect.com

[HTML][HTML] Clinicopathological characteristics of RET rearranged lung cancer in European patients

S Michels, AH Scheel, M Scheffler… - Journal of Thoracic …, 2016 - Elsevier
Introduction Rearrangements of RET are rare oncogenic events in patients with non–small
cell lung cancer (NSCLC). While the characterization of Asian patients suggests a …
被引用次数：84 相关文章 所有 9 个版本
[PDF] springer.com

Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter …

C Lu, XR Dong, J Zhao, XC Zhang, HJ Chen… - Journal of Hematology & …, 2020 - Springer
Background Rearranged during transfection (RET) has been proven to be a tumorigenic
target in non-small cell lung cancers (NSCLCs). In RET-rearranged NSCLCs, molecular …
被引用次数：44 相关文章 所有 12 个版本

Association between RET fusions and efficacy of pemetrexed-based chemotherapy for patients with advanced NSCLC in China: a multicenter retrospective study

T Shen, X Pu, L Wang, Z Yu, J Li, Y Zhang, X Liang… - Clinical Lung Cancer, 2020 - Elsevier
Background Rearranged during transfection (RET) proto-oncogene gene fusions are rare in
non–small-cell lung cancer (NSCLC). We compared the efficacy of pemetrexed-based …
被引用次数：30 相关文章 所有 5 个版本
[HTML] sciencedirect.com

[HTML][HTML] Molecular characterization and clinical outcomes in RET-rearranged NSCLC

AC Tan, AOL Seet, GGY Lai, TH Lim, AST Lim… - Journal of Thoracic …, 2020 - Elsevier
Introduction RET rearrangements are an emerging targetable oncogenic fusion driver in
NSCLC. However, the natural history of disease and activity of different classes of systemic …
被引用次数：34 相关文章 所有 3 个版本
[HTML] sciencedirect.com

[HTML][HTML] Clinical and translational implications of RET rearrangements in non–small cell lung cancer

R Ferrara, N Auger, E Auclin, B Besse - Journal of Thoracic Oncology, 2018 - Elsevier
Since the discovery in 2012 of rearranged during transfection proto-oncogene gene (RET)
rearrangements in NSCLC, at least 12 different fusion variants have been identified, with …
被引用次数：205 相关文章 所有 6 个版本

RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer

R Wang, H Hu, Y Pan, Y Li, T Ye, C Li, X Luo… - Journal of clinical …, 2012 - ascopubs.org
Purpose The RET fusion gene has been recently described in a subset of non–small-cell
lung cancers (NSCLCs). Because we have limited knowledge about these tumors, this study …
被引用次数：628 相关文章 所有 6 个版本
[PDF] springer.com

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients

G Wu, L Guo, Y Gu, T Huang, M Liu, X Zou… - Journal of Cancer …, 2023 - Springer
Abstract Background Approximately 1–2% of non-small cell lung cancer (NSCLC) patients
harbor RET (rearranged during transfection) fusions. The oncogenic RET fusions could lead …
被引用次数：5 相关文章 所有 11 个版本